2024-07-15T12:26:24-05:00 2023-12-31 521853933 JM&M 10500 LITTLE PATUXENT PARKWAY SUITE 770 COLUMBIA MD 21044 990 2023-01-01 043809491 CLINICAL RESEARCH FORUM INC CLIN 2023671176 2001 K ST NW 300 WASHINGTON DC 20006 ANDREA VAN HOOK EXECUTIVE DIRECTOR 2023671176 2024-07-11 1 ANDREA VAN HOOK XXX-XX-XXXX 1 SEAN MCELWANEY P01608821 4108840220 2 AAL1 IAL1 2023 2023-04-26 12:10:37Z ANDREA VAN HOOK 2001 K ST NW 300 WASHINGTON DC 20006 465518 0 X WWW.CLINICALRESEARCHFORUM.ORG X 2005 DE TO PROVIDE LEADERSHIP TO THE NATIONAL CLINICAL AND TRANSLATIONAL RESEARCH ENTERPRISE AND PROMOTE UNDERSTANDING AND SUPPORT FOR CLINICAL RESEARCH AND ITS IMPACT ON HEALTH AND HEALTHCARE. 16 16 0 16 0 0 5538 23000 403198 408478 16430 34040 0 0 425166 465518 17500 17500 0 0 0 0 0 0 0 422026 528716 439526 546216 -14360 -80698 950176 1080307 1010 171000 949166 909307 X TO PROVIDE LEADERSHIP TO THE NATIONAL CLINICAL AND TRANSLATIONAL RESEARCH ENTERPRISE AND PROMOTE UNDERSTANDING AND SUPPORT FOR CLINICAL RESEARCH AND ITS IMPACT ON HEALTH AND HEALTHCARE. 0 0 177434 17500 TOP TEN CLINICAL RESEARCH ACHIEVEMENT AWARDS - THE TOP TEN CLINICAL RESEARCH ACHIEVEMENT AWARDS HONOR OUTSTANDING ACCOMPLISHMENTS AND MAJOR ADVANCES RESULTING FROM THE NATION'S INVESTMENT IN RESEARCH TO BENEFIT THE HEALTH AND WELFARE OF ITS CITIZENS. 45870 535 ANNUAL MEETING - THE SENIOR LEADERSHIP MEETING IS AN ANNUAL CONVENING OF SENIOR LEADERS FROM ACADEMIC HEALTH CENTER MEMBER INSTITUTIONS. THIS FOCUSED, INTIMATE MEETING INCLUDES AN ADVOCACY AND POLICY UPDATE, INVITED SPEAKERS FROM RELEVANT GOVERNMENT AGENCIES, AND A STRATEGIC PLANNING DISCUSSION FOR THE ORGANIZATION. 43117 392150 MEMBERSHIP - THE MEMBERSHIP SERVICES INCLUDES DUES INVOICING AND PROCESSING AND DATABASE UPDATES OF ORGANIZATIONAL MEMBERS AND THEIR TEAMS SO THAT THEY CAN ACCESS THEIR BENEFITS, REGISTER FOR EVENTS, JOIN NEW MEMBER ORIENTATION, AND ACCESS COMMITTEE AND VOLUNTEER SUPPORT. 39497 ADVOCACY - THE COALITION FOR CLINICAL AND TRANSLATIONAL SCIENCE (CCTS) IS THE UNIFIED VOICE OF THE CLINICAL AND TRANSLATIONAL SCIENCE RESEARCH COMMUNITY, OF WHICH THE CLINICAL RESEARCH FORUM IS A MEMBER. STARTED AS A COALITION OF ORGANIZATIONS WITH A SHARED MISSION TO SUPPORT CLINICAL AND TRANSLATIONAL SCIENCE, CCTS HAS GROWN INTO A NATIONWIDE GRASSROOTS NETWORK OF DEDICATED INDIVIDUALS WHO WORK TOGETHER TO EDUCATE CONGRESS AND THE ADMINISTRATION ABOUT THE VALUE AND IMPORTANCE OF FEDERAL CLINICAL AND TRANSLATIONAL RESEARCH AND RESEARCH TRAINING AND CAREER DEVELOPMENT ACTIVITIES. 27034 15793 IT ROUNDTABLE - THE CLINICAL RESEARCH FORUM CONSIDERS THE INTEGRATION OF INFORMATION TECHNOLOGY (IT) AND CLINICAL RESEARCH A HIGH PRIORITY FOR ITS MEMBERS. THE IT ROUNDTABLE WAS INITIATED IN 2005 AND HAS CONTINUED TO BE ONE OF THE FORUM'S MOST ENGAGING INITIATIVES. ROUNDTABLE MEETINGS PROVIDE A VENUE FOR ACADEMIC HEALTH CENTER LEADERS TO SHARE EXPERIENCES AND WORK WITH VENDORS TO ADDRESS KEY IT ISSUES IN CLINICAL RESEARCH SUCH AS THE INTERFACE OF CLINICAL SERVICES AND CLINICAL RESEARCH DATA, WAREHOUSING, DATA SECURITY, ELECTRONIC HEALTH RECORD PLATFORMS, AND GOVERNANCE. 66531 15793 332952 0 0 0 1 0 0 0 0 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 X 16 16 0 1 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 0 0 0 X SMITHBUCKLIN CORPORATION 2023671176 2001 K ST NW 300 WASHINGTON DC 20006 X HARRY P SELKER MD MSPH CHAIR 4.00 X X 0 0 0 HERBERT PARDES MD VICE-CHAIR 3.00 X X 0 0 0 WILLIAM L LOWE JR MD SECRETARY/TREASURER 2.00 X X 0 0 0 BARRY S COLLER MD DIRECTOR 1.00 X 0 0 0 ANNE B CURTIS MD DIRECTOR 1.00 X 0 0 0 PAMELA DAVIS MD PHD DIRECTOR 1.00 X 0 0 0 MAURIZIO FAVA MD DIRECTOR 1.00 X 0 0 0 HARRY B GREENBERG MD DIRECTOR 1.00 X 0 0 0 RACHEL HESS MD MS DIRECTOR AS OF APRIL 2023 1.00 X 0 0 0 RAINU KAUSHAL MD DIRECTOR 1.00 X 0 0 0 EMMA MEAGHER MD DIRECTOR 1.00 X 0 0 0 E ALBERT REECE MD PHD MBA DIRECTOR 1.00 X 0 0 0 ARTHUR H RUBENSTEIN MBBCH DIRECTOR 1.00 X 0 0 0 ANANTHA SHEKHAR MD PHD DIRECTOR 1.00 X 0 0 0 CONSUELO H WILKINS MD MSCI DIRECTOR 1.00 X 0 0 0 DUANE MITCHELL MD PHD DIRECTOR AS OF APRIL 2023 1.00 X 0 0 0 ANDREA VAN HOOK EXECUTIVE DIRECTOR 15.00 X 0 0 0 0 0 0 0 0 0 0 SMITHBUCKLIN CORPORATION 2001 K STREET NW 3RD FLOOR NORTH WASHINGTON DC 20006 MANAGEMENT/ED COMPENSATION 385699 1 23000 23000 MEMBERSHIP DUES 900099 392150 392150 IT ROUNDTABLE DUES/REG 900099 15793 15793 CAREER CENTER 900099 535 535 408478 18986 18986 15054 0 15054 15054 15054 465518 408478 0 34040 17500 17500 370582 219048 151534 1005 1005 9300 9300 39408 39408 36054 11502 24552 13293 1597 11696 20664 20664 23526 22349 1177 5982 5982 DUES AND SUBSCRIPTIONS 6125 6125 MISCELLANEOUS 1308 1308 AWARDS 884 884 LICENSES, FEES AND TAXE 585 585 546216 332952 213264 0 346381 398398 3064 3584 3755 600211 675090 950176 1080307 1010 171000 1010 171000 X 882909 841203 66257 68104 949166 909307 950176 1080307 -80698 40839 0 X X 0 1 X 1 0 1 0 0 66257 9347 7500 68104 86974 -13217 7500 66257 89287 5187 7500 86974 87806 8981 7500 89287 82769 12537 7500 87806 1.00000 0 0 0 X PART V, LINE 4: A FUND WITH DONOR RESTRICTIONS HAS BEEN ESTABLISHED TO SUPPORT THE HERBERT PARDES CLINICAL RESEARCH EXCELLENCE AWARD. PER THE DONOR'S INSTRUCTIONS, THE CONTRIBUTED FUNDS AND RELATED EARNINGS THEREON ARE REQUIRED TO BE SEGREGATED IN A SEPARATE INVESTMENT ACCOUNT TO PAY AN ANNUAL AWARD. HOWEVER, IN THE EVENT THE INVESTED FUNDS DO NOT GENERATE SUFFICIENT INCOME IN A GIVEN YEAR, THE ORGANIZATION IS AUTHORIZED TO EXPEND ADDITIONAL FUNDS FROM THE RELATED INVESTMENTS TO MAKE AN AWARD. PART X, LINE 2: THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS OR THAT WOULD HAVE AN EFFECT ON ITS TAX-EXEMPT STATUS. THERE ARE NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES THAT NEED TO BE RECORDED. 1 THE HERBERT PARDES CLINICAL RESEARCH EXCELLENCE AWARD 1 7500 DISTINGUISHED CLINICAL RESEARCH ACHIEVEMENT AWARDS 2 10000 PART I, LINE 2: CRF AWARDS TEN ACHIEVEMENT AWARDS TO TOP RESEARCHERS. THE TOP THREE AWARDEES RECEIVE MONETARY RECOGNITION, THE REMAINING SEVEN DO NOT. AWARDS ARE RECOGNITIONS OF ACHIEVEMENT, SO NO MONITORING IS NEEDED. FORM 990, PART VI, SECTION A, LINE 3 THE CLINICAL RESEARCH FORUM, INC. (CRF) HAS ENTERED INTO A MANAGEMENT CONTRACT WITH SMITHBUCKLIN CORPORATION. UNDER THE TERMS OF THIS AGREEMENT, CRF MAKES PAYMENTS TO SMITHBUCKLIN WHICH COVER STAFF SALARIES, EXECUTIVE DIRECTOR, AND OTHER OVERHEAD EXPENSES. THE FEES INCURRED BY CRF DURING THE CURRENT FISCAL YEAR WERE $370,582 FOR THE FOLLOWING: EXECUTIVE MANAGEMENT - $87,528, MEMBERSHIP AND OPERATIONS SERVICES, EVENT SERVICES, MARKETING AND COMMUNICATIONS SERVICES, FINANCIAL MANAGEMENT AND ACCOUNTING SERVICES, INFORMATION TECHNOLOGY, AND PROMOTIONAL PRODUCTS AND SUPPORT. SMITHBUCKLIN'S PERFORMANCE UNDER THIS AGREEMENT IS MONITORED BY THE BOARD OF CRF. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION'S MEMBERS SHALL BE ACADEMIC HEALTH CENTERS THAT ARE INTERESTED IN PARTICIPATING IN THE ACTIVITIES OF THE CORPORATION OR SUPPORTING ITS MISSION AND PURPOSE AND THAT PAY DUES IN ACCORDANCE WITH THE CORPORATION'S REQUIREMENTS. FORM 990, PART VI, SECTION A, LINE 7A DIRECTORS SHALL BE ELECTED BY A PLURALITY OF THE VOTES CAST TO A THREE (3) YEAR TERM BY THE CRF MEMBERS AT THE ANNUAL MEETING OR AT ANY SPECIAL MEETING HELD IN LIEU THEREOF, FROM A SLATE OF ONE (1) OR MORE CANDIDATES SELECTED BY THE NOMINATING COMMITTEE FOR EACH OPEN POSITION. FORM 990, PART VI, SECTION A, LINE 7B EACH CRF MEMBER SHALL HAVE AN EQUAL VOTE AT EVERY MEETING OF THE MEMBERS. UNLESS OTHERWISE PROVIDED BY LAW, THE CERTIFICATE OF INCORPORATION OR THE BY-LAWS, AN AFFIRMATIVE VOTE OF THE MAJORITY OF THE CRF MEMBERS PRESENT AND ENTITLED TO VOTE SHALL DECIDE EVERY QUESTION. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY MANAGEMENT AND PROVIDED TO THE FINANCE/AUDIT COMMITTEE AND BOARD OF DIRECTORS BEFORE IT IS SIGNED AND FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD'S FINANCE COMMITTEE IS RESPONSIBLE FOR ENFORCING COMPLIANCE WITH THE ORGANIZATION'S CONFLICT OF INTEREST POLICY. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST. FORM 990, PART XII, LINE 2C: THE ORGANIZATION DID NOT CHANGE ITS AUDIT OVERSIGHT PROCESS OR SELECTION OF AN INDEPENDENT AUDITOR PROCESS DURING THE TAX YEAR. CLINICAL RESEARCH FOUNDATION INC 2001 K STREET NW 3RD FLOOR WASHINGTON DC 20006 020773588 INACTIVE/FURTHERING EFFECTIVE TRANSLATIONAL RESEARCH DE 501(C)(3) LINE 7 CLINICAL RESEARCH FORUM INC 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0